Guillain-Barre Syndrome

This is a serious nerve disorder that causes muscle weakness. It often starts with tingling or numbness in the feet and legs, then spreads upwards. It can affect breathing and other body functions, so it needs medical attention.

Condition

What people with Guillain-Barre Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried IVIG for Guillain-Barre Syndrome?

NameHow it went

About Guillain-Barre Syndrome

What It Is

Guillain-Barre syndrome (GBS) is a rare condition in which the immune system mistakenly attacks the peripheral nerves, the network that carries signals between the brain and spinal cord and the rest of the body. When those nerves are damaged, signals travel poorly, so muscles weaken and sensation changes. It usually starts with tingling, numbness or weakness in the feet and legs that spreads upward to the arms and sometimes the face, and reflexes such as the knee jerk fade or disappear. Many people also have deep aching pain in the back or legs. What makes GBS serious is its speed. Weakness can build over hours or days, and in severe cases it reaches the muscles used for breathing and swallowing or disturbs the automatic nerves that control heart rate and blood pressure. Some cases are mild, while others cause near-complete paralysis. Most people eventually recover, but the early weeks often require hospital care. GBS has several forms. The most common damages myelin, the insulating coating around nerve fibers; other forms damage the nerve fibers themselves and can take longer to heal. Miller Fisher syndrome, a variant, mainly affects eye movements, balance and reflexes and usually runs a milder course.

Causes & Risk Factors

GBS is not contagious and is not inherited. About two-thirds of people had an infection in the six weeks before symptoms began, most often a respiratory illness or a stomach bug with diarrhea. One common culprit is Campylobacter, a bacterium that causes food-borne diarrheal illness; cytomegalovirus, Epstein-Barr virus, hepatitis E, Mycoplasma pneumonia and Zika virus have also been linked. The leading explanation is that the immune response to the infection cross-reacts with similar-looking molecules on nerves. By the time weakness starts, the infection has usually cleared, and many people never notice one at all. GBS can affect anyone, but it becomes more common with age and is somewhat more common in men. Surgery has occasionally preceded it, though that link is less certain. Some flu vaccines have been associated with roughly one additional case per million doses, a risk far smaller than the risks of the infections the vaccines prevent. Having had GBS does not automatically rule out future vaccines, but it is worth discussing each one with a clinician, especially within a year of the illness or if GBS followed that same vaccine before.

How It's Diagnosed

There is no single test that confirms GBS. Diagnosis rests mainly on the pattern a clinician sees: weakness on both sides of the body that worsens over days rather than months, along with reduced or absent reflexes. Because early symptoms can be vague, GBS can be hard to recognize in its first days, especially when pain or tingling comes before obvious weakness. Two tests help support the diagnosis. A spinal tap (lumbar puncture) samples the fluid around the spinal cord; in GBS it typically shows raised protein without a rise in white blood cells. Nerve conduction studies measure how fast and how strongly electrical signals travel along nerves and can show the damage and which form of GBS is present. Both can still look normal in the first week, so a normal result early on does not rule GBS out, and tests may be repeated. Blood tests, and sometimes magnetic resonance imaging (MRI) of the spine or brain, help exclude other causes of sudden weakness such as spinal cord problems, stroke, electrolyte imbalances or other nerve disorders. Treatment usually starts on clinical grounds without waiting for every result.

Treatment Options

There is no cure for GBS, but treatment can calm the immune attack and help people recover sooner. Most people are admitted to the hospital, where staff track muscle strength, breathing capacity, heart rate and blood pressure, sometimes in an intensive care unit. If breathing muscles weaken, a ventilator (breathing machine) can take over until they recover. Two treatments are proven to help, and they work about equally well. Intravenous immunoglobulin (IVIg) is a concentrated preparation of antibodies collected from many healthy blood donors, given through a vein daily for about five days. Plasma exchange (plasmapheresis) removes the liquid part of the blood, which carries the harmful antibodies, and replaces it, usually over four or five sessions. IVIg is used more often because it is simpler to give and more widely available. These treatments are aimed at people whose weakness is significant, such as those who cannot walk unaided, and work best when started within the first two to four weeks. They limit further damage but do not instantly reverse it, so some people keep worsening for a few days before stabilizing. People with mild weakness or Miller Fisher syndrome may be monitored closely without either treatment. Steroids, which help many other immune conditions, do not help GBS and are not recommended. Supportive care matters as much as the immune treatment: preventing blood clots, protecting the airway when swallowing is weak, and managing nerve pain with medicines such as gabapentin or certain antidepressants. Physical, occupational and speech therapy begin early and continue into rehabilitation.

What to Expect

GBS usually follows a predictable arc. Weakness peaks within about two weeks, then holds steady for days to weeks before recovery begins. Recovery then happens gradually as nerves repair, often over months and sometimes over a few years. About 80% of people can walk on their own six months after onset, and even people who needed a ventilator often recover substantially, especially in the first year. GBS remains a serious illness, however: a small share of people, more often older adults or those with severe disease, die from breathing or heart complications despite good care. Many people leave the hospital for a rehabilitation unit or continue intensive therapy at home. Physical therapy rebuilds strength and walking, occupational therapy helps with daily tasks and returning to work, and graded exercise is paced carefully because overexertion worsens fatigue. Lingering effects are common. Fatigue affects most survivors for a time, and some have ongoing pain, numbness or weakness, though improvement can continue for years. The sudden loss of independence can be frightening, and anxiety or depression during recovery deserves attention as part of treatment. Talking with others who have had GBS, through patient organizations or support groups, helps many people. GBS usually happens only once. A second episode occurs in about 2 to 5% of people.

When to Seek Help

See a clinician the same day if you develop tingling or weakness in both feet or legs that is spreading or worsening over hours to days, particularly after a recent infection, such as new trouble climbing stairs or getting up from a chair. Trouble breathing, breathlessness when talking or lying flat, difficulty swallowing or choking, or fainting or a racing or irregular heartbeat alongside this kind of weakness is an emergency: call 911 or go to an emergency department. If you are recovering from GBS and your strength worsens again after improving or leveling off, contact your neurology team promptly, since this can signal a flare that needs more treatment or a chronic form of the condition.

Questions to Ask Your Doctor

  1. 1.Which form of GBS do I have, and how does it affect my expected recovery?
  2. 2.Is my weakness severe enough to need IVIg or plasma exchange, and how will we judge whether it is working?
  3. 3.What signs would mean my breathing or swallowing needs closer monitoring?
  4. 4.What rehabilitation should I plan for, and how should I pace activity while fatigue persists?
  5. 5.How should we approach future vaccinations given my history of GBS?

Last reviewed • Oct 2026

Educational content, not medical advice.